vanadates has been researched along with thromboxane a2 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishii, K; Masumoto, N; Nakayama, K; Obara, K; Oyabe, A; Tanabe, Y; Uchino, M | 1 |
Baranowska-Bosiacka, I; Chlubek, D; Gutowska, I; Korbecki, J; Piotrowska, K | 1 |
2 other study(ies) available for vanadates and thromboxane a2
Article | Year |
---|---|
Specific attenuation of the pressure-induced contraction of rat cerebral artery by herbimycin A.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Benzoquinones; Catechols; Cerebral Arteries; Genistein; In Vitro Techniques; Isoflavones; Lactams, Macrocyclic; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nitriles; Potassium Chloride; Pressure; Prostaglandin Endoperoxides, Synthetic; Protein-Tyrosine Kinases; Quinones; Rats; Rats, Sprague-Dawley; Rifabutin; Thromboxane A2; Tyrphostins; Vanadates; Vasoconstrictor Agents | 1997 |
Cyclooxygenase-1 as the main source of proinflammatory factors after sodium orthovanadate treatment.
Topics: Air Pollutants; Cell Line, Tumor; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Gene Expression Regulation, Enzymologic; Humans; Inflammation Mediators; RNA, Messenger; Thromboxane A2; Thromboxane B2; Vanadates | 2015 |